Single-Use Bioreactors Market is set to Reach US$ 19.30 billion at a CAGR of 20.89% from the forecast period 2023 to 2031 | Growth Plus Reports

Pune, Feb. 08, 2024 (GLOBE NEWSWIRE) — According to the latest report published by Growth Plus Reports, the global Single-use Bioreactors Market is expected to clock US$ 19.30 billion by 2031 and to grow at a CAGR of 20.89% during the forecast period.

The global Single-Use Bioreactors Market is experiencing remarkable growth, fueled by the increasing adoption of single-use technologies in bioprocessing, advancements in biopharmaceutical manufacturing, and the demand for flexible and cost-effective production solutions. A comprehensive analysis of the market reveals a dynamic landscape dedicated to revolutionizing biomanufacturing processes and accelerating the development of biopharmaceuticals.

Get a Sample Copy of the Research Report:

                         Single-use Bioreactors Market Scope

Report Attribute Details
Market Size Value in 2022 US$ 3.5 billion
Revenue Forecast in 2031 US$ 19.30 billion
CAGR 20.89%
Base Year for Estimation 2022
Forecast Period 2023-2031
Historical Year 2021
Segments Covered Product Type, Cell Type, Molecule Type, End User, and Region
Regional Scope North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Market Overview:
Single-use bioreactors (SUBs) are innovative bioprocessing systems designed for the cultivation of cells and production of biological products in a disposable, single-use format. The Single-Use Bioreactors Market encompasses a wide range of SUBs, including stirred-tank bioreactors, wave-mixed bioreactors, and disposable rocker bioreactors, offering advantages such as reduced cross-contamination risks, simplified cleaning and sterilization processes, and increased manufacturing flexibility.

Key Market Drivers:

  1. Rapid Expansion of Biopharmaceutical Industry: The rapid growth of the biopharmaceutical industry, driven by increasing demand for biologics, biosimilars, and personalized medicine, fuels the adoption of single-use bioreactors. SUBs offer scalability, rapid turnaround times, and cost advantages over traditional stainless steel bioreactors, making them well-suited for the production of a wide range of biopharmaceutical products.
  1. Advancements in Single-Use Technologies: Ongoing advancements in single-use technologies, including biocompatible materials, sensor integration, and disposable downstream processing solutions, drive innovation in single-use bioreactors. These technological advancements enhance process monitoring, control, and automation capabilities, enabling biomanufacturers to achieve higher yields, improved product quality, and faster time-to-market for biopharmaceuticals.
  1. Focus on Operational Efficiency and Cost Reduction: Biopharmaceutical companies increasingly prioritize operational efficiency and cost reduction in bioprocessing operations. Single-use bioreactors offer significant advantages in terms of reduced capital investment, minimized facility footprint, and streamlined manufacturing workflows, leading to lower operating costs and improved overall process economics.

Competitive Landscape:
The global Single-Use Bioreactors market features a competitive landscape with key players driving innovation and market expansion. The report profiles major companies, offering insights into their product portfolios, market share, strategic collaborations, and recent developments.

Challenges and Opportunities:
While the Single-Use Bioreactors Market presents significant opportunities, challenges such as concerns about extractables and leachables, scalability limitations, and the need for standardization and regulatory harmonization need to be addressed. However, ongoing research, technological innovations, and the potential for market penetration in emerging economies offer avenues for growth and development in single-use bioreactor technologies.

Table of Content

    1. Market Ecosystem
    2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
    3. Currency Used in the Report
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources
    4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2022)
    3. Regulatory Landscape
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
    1. Single-Use Media Bags
      1. 2D Bags
      2. 3D Bags
      3. Others
    2. Single-Use Bioreactor Systems
      1. Up to 10L
      2. 11-100L
      3. 101-500L
      4. 501-1500L
      5. Above 1500L
    3. Single-Use Filtration Assemblies
    4. Other Products
    1. Bacterial Cells
    2. Mammalian Cells
    3. Yeast
    4. Other Cell Types
    1. Monoclonal Antibodies
    2. Stem Cells
    3. Recombinant Proteins
    4. Vaccines
    5. Others
    1. Pharmaceutical & Biopharmaceutical Companies
    2. CROs & CMOs
    3. Academic & Research Institutes

Browse full TOC here

Future Outlook:
The report provides a forward-looking perspective on the Single-Use Bioreactors market, offering insights into potential growth opportunities, emerging trends, and factors that could shape the market in the coming years. With a focus on enhancing bioprocessing efficiency, increasing manufacturing flexibility, and meeting evolving regulatory requirements, the global market is poised for continued expansion and innovation in single-use bioreactor solutions.

In conclusion, the report serves as a valuable resource for biopharmaceutical companies, contract manufacturers, investors, and other stakeholders, providing a comprehensive analysis of market trends, challenges, and opportunities. As single-use bioreactors continue to redefine biomanufacturing practices and drive the development of next-generation biopharmaceuticals, the Single-Use Bioreactors Market is poised to witness sustained growth and contribute to advancing healthcare worldwide.


  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives
  • Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market


  • Distributor Landscape Assessment
  • Pricing Intelligence
  • Customer Base Assessment
  • Investment & Initiatives Analysis
  • ‘Business Profile’ of Key Players

Buy this Premium Research Report:

Browse other reports:

According to the deep-dive market assessment study by Growth Plus Reports, the global cell & tissue preservation market was valued at US$ 3.6 billion in 2022 and is expected to register a revenue CAGR of 12.2% to reach US$ 11.3 billion by 2031. 

According to the deep-dive market assessment study by Growth Plus Reports, the global cloning and mutagenesis market was valued at US$ 2.45 billion in 2022 and is expected to register a revenue CAGR of 17.12% to reach US$ 10.15 billion by 2031.

According to the deep-dive market assessment study by Growth Plus Reports, the global healthcare chatbots market was valued at US$ 237 million in 2022 and is expected to register a revenue CAGR of 18.9% to reach US$ 949 million by 2031.

According to the deep-dive market assessment study by Growth Plus Reports, the global infant incubators market was valued at US$ 334.0 million in 2022 and is expected to register a revenue CAGR of 4.4% to reach US$ 471.0 million by 2031.

According to the deep-dive market assessment study by Growth Plus Reports, the global intra-compartmental pressure measuring systems market was valued at US$ 16.6 million in 2022 and is expected to register a revenue CAGR of 12.4% to reach US$ 47.6 million by 2031. 

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as Most Innovative Healthcare Market Research Company in 2020.

CONTACT: Manan Sethi Director, Market Insights Email: Phone no: +1 888 550 5009 Web:  Follow Us: LinkedIn | Twitter

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.